Similar articles for PMID: 25151800

Year	Number of Results
1987	1
1990	1
1993	4
1994	1
1995	1
1996	3
1997	1
1999	1
2000	1
2001	1
2002	5
2003	2
2004	6
2005	1
2006	2
2007	3
2008	6
2009	3
2011	1
2012	2
2013	1
2014	11
2015	4
2016	6
2017	1
2018	2
2019	1
2022	1
2024	0

1

[Lung cancer: progress in diagnosis and treatments. Topics: III. Treatment; 7. Lung cancer treatment in elderly and/or high risk patients].

Kimura T, Kudoh S, Hirata K. Kimura T, et al. Nihon Naika Gakkai Zasshi. 2014 Jun 10;103(6):1346-54. doi: 10.2169/naika.103.1346. Nihon Naika Gakkai Zasshi. 2014. PMID: 25151800 Review. Japanese. No abstract available.

2

Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.

Fiteni F, Vernerey D, Bonnetain F, Vaylet F, Sennélart H, Trédaniel J, Moro-Sibilot D, Herman D, Laizé H, Masson P, Derollez M, Clément-Duchêne C, Milleron B, Morin F, Zalcman G, Quoix E, Westeel V. Fiteni F, et al. Eur J Cancer. 2016 Jan;52:120-8. doi: 10.1016/j.ejca.2015.10.004. Epub 2015 Dec 10. Eur J Cancer. 2016. PMID: 26682871 Clinical Trial.

3

Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).

Costa GJ, Fernandes AL, Pereira JR, Curtis JR, Santoro IL. Costa GJ, et al. Lung Cancer. 2006 Aug;53(2):171-6. doi: 10.1016/j.lungcan.2006.04.006. Epub 2006 Jun 6. Lung Cancer. 2006. PMID: 16757059

4

Duration of chemotherapy for metastatic non-small-cell lung cancer: more may be better after all.

Schiller JH, Ramalingam SS. Schiller JH, et al. J Clin Oncol. 2009 Jul 10;27(20):3265-7. doi: 10.1200/JCO.2009.22.9955. Epub 2009 May 26. J Clin Oncol. 2009. PMID: 19470911 No abstract available.

5

Chemotherapy for lung cancer.

Locke I, Gillham CM. Locke I, et al. N Engl J Med. 2002 May 9;346(19):1498; author reply 1498. doi: 10.1056/NEJM200205093461914. N Engl J Med. 2002. PMID: 12000824 No abstract available.

6

Adjuvant chemotherapy for lung cancer.

Morgan GW. Morgan GW. N Engl J Med. 2004 Apr 15;350(16):1681-3; author reply 1681-3. N Engl J Med. 2004. PMID: 15088321 No abstract available.

7

Polychemotherapy in advanced non-small-cell lung cancer.

Rodger A. Rodger A. Lancet. 1993 Sep 18;342(8873):740-1; author reply 741-2. Lancet. 1993. PMID: 8103839 No abstract available.

8

Missing patient-reported outcome data in an adjuvant lung cancer study.

Land SR. Land SR. J Clin Oncol. 2008 Nov 1;26(31):5018-9. doi: 10.1200/JCO.2008.18.2154. Epub 2008 Sep 22. J Clin Oncol. 2008. PMID: 18809601 No abstract available.

9

Study Protocol of the NVALT25-ELDAPT Trial: Selecting the Optimal Treatment for Older Patients With Stage III Non-small-cell Lung Cancer.

Driessen EJM, Janssen-Heijnen MLG, Maas HA, Dingemans AC, van Loon JGM. Driessen EJM, et al. Clin Lung Cancer. 2018 Nov;19(6):e849-e852. doi: 10.1016/j.cllc.2018.07.003. Epub 2018 Jul 9. Clin Lung Cancer. 2018. PMID: 30097357

10

Chemotherapy for advanced non-small cell lung cancer in the elderly population.

Santos FN, Castria TB, Cruz MR, Riera R. Santos FN, et al. Sao Paulo Med J. 2016 Sep-Oct;134(5):465-466. doi: 10.1590/1516-3180.20161345T1. Sao Paulo Med J. 2016. PMID: 27901246 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

68 results

Results by year